We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

9 hedge funds and large institutions have $2.05M invested in Coeptis Therapeutics Warrants in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
$763K
Puts
–
Net Calls
+$763K
Net Calls Change
+$763K

Top Buyers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
+$364K
2
SCM
Shaolin Capital Management
Florida
+$348K
3
ICM
Ionic Capital Management
New York
+$305K
4
BCM
Basso Capital Management
Connecticut
+$163K
5
Walleye Capital
Walleye Capital
New York
+$69.4K

Top Sellers

No sellers this quarter

COEPW Hedge Fund Activity: Q4 2020 in Review

9 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2020, worth a combined $2.05M.

Buyers outnumbered sellers: 9 funds opened new COEPW positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $364K.

  • 9 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $2.05M of Coeptis Therapeutics Warrants stock for Q4 2020.
  • 9 funds opened new Coeptis Therapeutics Warrants positions in Q4 2020 and 0 closed out, a net change of +9 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q4 2020 was Owl Creek Asset Management, an estimated $364K added.

Based on aggregated 13F filings for Q4 2020.